Integrated DNA Technologies (IDT), a Danaher company, is hiring a Senior Director, CCIA Portfolio Strategy & Business Development. In this remote role, you will be responsible for the Clinical Chemistry and Immunoassay (CCIA) portfolio strategy and driving inorganic innovation through business development activities. You will lead the development of business unit strategy and manage its evolution through the Strategic Innovation Review process.
What You'll Do
- Lead portfolio strategy development and the annual Strategic Innovation Review (SIR) process to build cohesive rationalized product roadmaps.
- Conduct adjacent market assessments, complex analyses and early technology assessments to support decision making around organic and inorganic options.
- Lead negotiations and contract or term sheet structuring with potential and current partners with direct tie to business and financial success.
- Lead new and novel biomarker scouting initiatives, including the pre-IDP tollgate evaluation process, in partnership with Product Management, R&D, Scientific and Medical Affairs, Global Market Access, and Legal.
- Partner with CCIA Business Unit leadership to cultivate open innovation opportunities and manage the funnel to advance execution of technology roadmaps.
- Partner with Legal to identify opportunities for creating Intellectual Property (IP Thicket) and opportunities for in- and out-licensing.
- Partner with Danaher Business Development to identify and assess M&A opportunities.
What We're Looking For
- 20+ years of experience with a Bachelor's degree in biological sciences, engineering and/or medicine OR 18+ years of experience with a Master's degree in biological sciences, engineering and/or medicine.
- Proven track record of success in leading strategy development; sourcing, negotiating and executing on high-impact partnerships within the Diagnostics industry or a related field.
- Deep knowledge of the healthcare industry, including how innovative healthcare technologies get to market and what drives their success.
- Excellent analytical and strategic thinking skills, with a strong track record of translating market insights into actionable strategies and product roadmaps.
- Collaborative leadership style, with a strong track record of driving results with buy-in within matrixed organizations.
- Experience building and coaching high performing teams and effectively managing change.
- Experience in a continuous improvement environment.
- Extensive experience in effectively communicating complex technical information to diverse audiences and championing innovation cross-functionally.
Nice to Have
- Ph.D. and/or M.D.
- 5+ years of Immunoassay and Clinical Chemistry Diagnostics product management and/or product development, with a strong understanding of the IVD product development lifecycle.
- Experience partnering with external organizations to deliver new product innovation and incremental revenue.
- Experience in precision medicine, companion diagnostics, or in neurodegenerative, infectious, and cardiac disease areas.
Team & Environment
You will be part of the Clinical Chemistry & Immunoassay Product and Program Management leadership team, reporting to the Vice President, Clinical Chemistry & Immunoassay Innovation, Product & Program Management.
Benefits & Compensation
- Compensation range: $215,000 - $260,000 plus bonus/incentive pay.
- Paid time off.
- Medical, dental, and vision insurance.
- 401(k) plan.
Work Mode
This is a fully remote position open to candidates located within the United States.
Danaher Corporation and all Danaher Companies, including IDT, are committed to equal opportunity regardless of race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
